Skip to main content
Clinical Trials/RBR-2rcm2g
RBR-2rcm2g
Recruiting
Phase 2

Safety and efficacy of different regimens of Primaquine on Vivax Malaria treatment in Glucose-6-phospate Dehydrogenase Deficient patients admitted at the Fundação De Medicina Tropical Doutor Heitor Vieira Dourado, Manaus, Amazonas

Fundação de Medicina Tropical Heitor Vieira Dourado - FMTHVD0 sitesFebruary 7, 2018

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Anemia due to glucose-6-phospate dehydrogenase deficiency
Sponsor
Fundação de Medicina Tropical Heitor Vieira Dourado - FMTHVD
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 7, 2018
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
Fundação de Medicina Tropical Heitor Vieira Dourado - FMTHVD

Eligibility Criteria

Inclusion Criteria

  • Male and female patients; older than 6 months of age; diagnosed with uncomplicated vivax malaria; with enzymatic activity between 10\-60%

Exclusion Criteria

  • Patients with severe malaria; hemoglobin levels below 9 g/dL; pregnant or breastfeeding females; children less than 6 months old; with severe enzymatic deficiency (enzymatic activity less than 10%); nephropathy; hepatopathy; under the use of potentially hemolytic drugs specified in the project; under the use of antimalarial drugs until two weeks before the study

Outcomes

Primary Outcomes

Not specified

Similar Trials